Argonaut Therapeutics
Is a precision therapeutics company that was established to develop epigenetically-acting drugs which target abnormal arginine methylation in cancer. The company was founded on pioneering research from the University of Oxford, UK. Argonaut Therapeutics strives to develop a new class of precision cancer medicines which target the enzymes responsible for abnormal arginine methylation in cancer.
Our mission
Argonaut Therapeutics is a precision medicine company developing transformative epigenetic therapeutics to treat cancer.
News
Argonaut Therapeutics Announces Successful Completion of Financing Round
The investment will advance Argonaut’s arginine methylation inhibitor drug candidate towards the clinic and enable…
Investors
Read more
Read more
Read more